Determination of the presence of specific bacteria in amniotic fluid collected by amniocentesis using multiple RT-PCR test.
Preterm Premature Rupture of Membranes (PPROM) is a pregnancy complication. In this condition, the sac (amniotic membrane) surrounding the fetus breaks (ruptures) before week 37 of pregnancy. Once the sac breaks, pregnant woman has increased risk for infection. PPROM complicates 3 – 4% of all pregnancies and is up to 1/3 complicated by microbial invasion of the amniotic cavity (MIAC) leading to infection in amniotic fluid (AF) and development of intra-amniotic inflammation. Although this complication is usually asymptomatic, it is a major cause of preterm birth and neonatal morbidity and mortality worldwide. Neonates from these pregnancies are at increased risk of developing neonatal sepsis and impaired psychomotor development and other sometimes lifelong health consequences. Currently, determining the MIAC in patients with PPROM is very time-consuming and technically demanding. Main disadvantage is that results are available in days, which is already clinically irrelevant for the initiation of targeted antibiotic treatment.
We have developed multiplex Real Time - PCR (Real - Time Polymerase Chain Reaction) assay for simultaneous detection of the most common targeted pathogens in AF collected by amniocentesis. The method will reduce the time required to diagnose specific pathogen and help clinicians make quick and accurate treatment decision. The assay consists of 3 panels for DNA detection of 8 most common microorganisms. Each panel contains specific sets of primers and probes. Assay results are determined by PCR fluorescence signal. Panels were validated retrospectively on 20 samples of AF of PPROM patients and have reached 90 % sensitivity so far. Further prospective validation study is currently underway.
Advantages
High sensitivity of the method - panel of selected microorganisms in multiplex assay was defined on the basis of research in nearly 700 patients with PPROM and it covers 88 % of microorganisms responsible for MIAC in PPROM patients. The multiplex approach determines the selected microbes in several hours after sampling in semi-quantitative way compare to the current approach (combination of specific multiplex Real Time - PCR for 3microorganisms in combination with PCR assay targeting 16S rRNA regions followed by Sagner sequencing for the rest of targeted microbes and cultivation techniques). Personalized approach to the clinical management and therapeutic intervention of the patients with PPROM based on the assay results. The technology does not require specialized laboratory equipment or specialized personnel and thus is suitable for molecular laboratory of perinatology centres equipped with standard Real-Time PCR cycler.
Technology is owned by University Hospital Hradec Králové and is being investigated within the PERSONMED project (CZ.02.1.01/0.0/0.0/17_048/0007441). Intellectual property is protected withknow-how. Technology is currently going through Proof of Conceptstage of development. Potential application is IVD test - POCT is intended to be used my medical facilities that take care of pregnant women esp. regional hospitals or perinatology centers. Our final product is planned to beIVD test (guideline EU 2017/746). We are searching forpartner- IVD manufacturer (Generi Biotech, Biovendor, Genespector, Roche).
Intellectual property status
Know-how
Current development status
Proof of Concept
University Hospital Hradec Králové is now one of the largest medical facilities not only in Eastern Bohemia but also throughout the Czech Republic. It is a state-of-the-art facility spanning a wide range of medical fields and serves as a catchment center for approximately 1,000,000 inhabitants from all over the Czech Republic.
More than 41,000 patients are hospitalized every year at the hospital’s 39 workplaces, which include 24 departments and over 1370 beds, with approximately 715,000 outpatients treated annually. The most complex surgical procedures are performed and modern diagnostic and treatment technologies are used. This makes University Hospital Hradec Králové comparable with similar hospitals in Europe.
University Hospital is an important research and educational institution closely connected with the Faculty of Medicine in Hradec Králové.
Create your free account to connect with University Hospital Hradec Králové and thousands of other innovative organizations and professionals worldwide
Send a request for information
to University Hospital Hradec Králové
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
